Injecto Polymers Limited Files DRHP for ₹56.14 Cr Fresh Equity Issue to Fund Capacity Expansion and Debt Reduction

Mumbai, 24 September 2025: Injecto Polymers Limited, a Kolkata-based manufacturer and trader of plastic polymer packaging solutions, has filed its Draft Red Herring Prospectus (DRHP) for a fresh issue of up to 56,13,500 equity shares on the BSE SME platform. The move is aimed at financing its Phase IV capacity expansion at Unit I in West Bengal and repaying certain borrowings, with the remaining proceeds allocated for general corporate purposes.

The Book Running Lead Manager (BRLM) is Indcap Advisors Private Limited, and Integrated Registry Management Services Private Limited has been appointed as the registrar. The listing is proposed on BSE SME, with the minimum application set at two lots. The final price band will be disclosed closer to the opening of the offer.

Injecto Polymers Limited, headquartered in Kolkata, operates in the packaging sector, manufacturing and trading plastic polymer products. Its offerings span PP woven fabrics and bags, BoPP bags, leno bags, pouches, FIBC bags, non-woven bags, as well as trading in plastic granules and PVC resins. The company caters primarily to B2B clients across agriculture, construction, textiles, chemicals, and consumer segments, operating from two facilities in West Bengal..

Fresh Issue of 100 Percent Equity Targets ₹56.14 Crore for Expansion and Debt Reduction

Injecto Polymers has opted for a 100 percent fresh issue, with no offer for sale, raising a total of approximately ₹56.14 crore. Out of this, up to ₹29.29 crore will be utilised for Phase IV expansion at its Unit I facility in Jaugram, West Bengal, while ₹12.60 crore will go towards prepayment or repayment of borrowings. The remaining funds will be deployed for general corporate purposes within regulatory limits. The company’s strategic focus on debt reduction and capacity augmentation signals a structured approach to scaling operations while managing financial leverage.

Phase IV Expansion to Add 4,800 MT Annual Capacity, Production Scheduled for June 2026

The proposed Phase IV expansion is expected to enhance the company’s production capacity by approximately 4,800 metric tonnes per annum at Unit I, supplementing the output from Phase III. Project execution, including site development, machinery procurement, and installation, is planned across FY26, with commercial production targeted for June 2026, subject to regulatory approvals. The expansion is designed to strengthen the company’s footprint across key packaging segments including PP woven fabrics, BoPP bags, leno bags, pouches, FIBC bags, and non-woven bags, serving agriculture, construction, textiles, chemicals, and consumer sectors.

Financial Performance Shows Steady Growth in Revenue, Profit, and Net Worth

Injecto Polymers reported a significant increase in total revenue to ₹26,185.35 lakh in FY25, up from ₹10,979.54 lakh in FY24 and ₹9,661.81 lakh in FY23. Profit after tax rose sharply to ₹810.96 lakh in FY25 from ₹444.36 lakh in FY24, reflecting consistent operational improvement and scale benefits. Net worth more than doubled to ₹4,732.88 lakh compared with ₹2,121.92 lakh in FY24, while total borrowings increased to ₹10,111.42 lakh from ₹8,335.23 lakh, indicating strategic leveraging to support expansion plans. The financial trajectory highlights robust growth backed by capacity utilisation and diversification across multiple packaging products.

Promoters and Shareholding Structure to Dilute Equally Post Fresh Issue

The promoters include Ramesh Kumar Rateria and Ashok Kumar Rateria, along with corporate promoters such as Suman Financial Advisory, Suman Towers, Vinayak Tie-up, Nivedeeka Commercial, and Bhagyashri Trading. As the issue comprises entirely fresh equity, the existing promoter shareholding will dilute proportionately upon allotment.

The DRHP filing by Injecto Polymers underscores a clear strategy to expand production capacity and reduce debt, while reinforcing operational capabilities across key packaging segments. The Phase IV expansion and strategic allocation of proceeds reflect a measured approach to scaling operations and strengthening the company’s financial base.

REF: https://www.bsesme.com/download/372306/SME_IPO InPrinciple/InjectoPolymersLtdDRHP_20250923201535.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations